Senti Biosciences Holdings convened its virtual 2026 Annual Meeting of Stockholders but adjourned without conducting business to allow more time to solicit shareholder support for the Merger Agreement Proposal. The meeting will reconvene on October 15, 2026, at 8:00 a.m. Pacific time via the internet. No changes have been made to the proposals, and polls remain open. Senti Biosciences is a synthetic biology company developing engineered cell therapies.
